Fenglin Zang

715 total citations
22 papers, 211 citations indexed

About

Fenglin Zang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Fenglin Zang has authored 22 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Fenglin Zang's work include Genetic factors in colorectal cancer (4 papers), Ferroptosis and cancer prognosis (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Fenglin Zang is often cited by papers focused on Genetic factors in colorectal cancer (4 papers), Ferroptosis and cancer prognosis (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Fenglin Zang collaborates with scholars based in China, Canada and United States. Fenglin Zang's co-authors include Xiyin Wei, Man Yu, Baocun Sun, Xue Leng, Ruifang Niu, Lujun Zhao, Zhiyong Yuan, Ximei Zhang, Baozhong Zhang and Yurong Shi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Fenglin Zang

20 papers receiving 210 citations

Peers

Fenglin Zang

ONCOL

IMMUN

PRM

Esperanza Martín‐Sánchez Spain

Hengyu Lu United States

Nazia Riaz Pakistan

James J. Saller United States

Anne‐Katrin Zimmermann Switzerland

Akira Okimura Japan

Monika Kowal Poland

Sofía del Carmen Spain

Mona Amini‐Adlé France

Nathalie Rioux-Leclerc France

Esperanza Martín‐Sánchez Spain

Fenglin Zang

118 ×1.3

65 ×0.9

ONCOL

44 ×0.9

IMMUN

80 ×1.7

26 ×0.6

PRM

Citations per year, relative to Fenglin Zang Fenglin Zang (= 1×) peers Esperanza Martín‐Sánchez

Countries citing papers authored by Fenglin Zang

Since Specialization

Citations

This map shows the geographic impact of Fenglin Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenglin Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenglin Zang more than expected).

Fields of papers citing papers by Fenglin Zang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenglin Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenglin Zang. The network helps show where Fenglin Zang may publish in the future.

Co-authorship network of co-authors of Fenglin Zang

This figure shows the co-authorship network connecting the top 25 collaborators of Fenglin Zang. A scholar is included among the top collaborators of Fenglin Zang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenglin Zang. Fenglin Zang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Huan-Huan, Yuanyuan Yan, Yong Wang, et al.. (2025). The efficacy and safety of neoadjuvant and adjuvant chemo(radio)therapy combined with surgery in patients with locally advanced rectal cancer harboring defective mismatch repair system: a large-scale multicenter propensity score analysis. Frontiers in Immunology. 16. 1626438–1626438.

Wang, Yong, Fenglin Zang, Bing Shao, et al.. (2024). From bioinformatics to clinical applications: a novel prognostic model of cuproptosis-related genes based on single-cell RNA sequencing data in hepatocellular carcinoma. BMC Immunology. 25(1). 59–59. 2 indexed citations

Ning, Junya, Yingnan Ye, Hongru Shen, et al.. (2024). Macrophage-coated tumor cluster aggravates hepatoma invasion and immunotherapy resistance via generating local immune deprivation. Cell Reports Medicine. 5(5). 101505–101505. 12 indexed citations

Li, Hongli, Shaohua Ge, Fenglin Zang, et al.. (2024). Updated results of perioperative PD-1 antibody toripalimab plus FLOT chemotherapy for locally advanced resectable gastric or gastro-esophageal junction adenocarcinoma: A one-arm open-table phase II trial.. Journal of Clinical Oncology. 42(16_suppl). e16128–e16128. 1 indexed citations

Wang, Yong, Xiyin Wei, Bin Ke, et al.. (2023). Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation. Histopathology. 83(4). 631–646. 5 indexed citations

Zang, Fenglin, et al.. (2022). [Intrahepatic adrenocortical oncocytic adenoma arising from ectopic adrenal: report of a case].. PubMed. 51(8). 782–784.

Song, Tianqiang, Ti Zhang, Huikai Li, et al.. (2022). Conversion of initially unresectable hepatocellular carcinoma (HCC) with triple-combination therapy (lenvatinib, anti-PD-1 antibodies, and transarterial therapy): A retrospective analysis.. Journal of Clinical Oncology. 40(4_suppl). 413–413. 10 indexed citations

Liu, Yujie, Fenglin Zang, Ye Luo, et al.. (2021). [Association of status of mismatch repair protein expression and EB virus infection with clinicopathological parameters in 886 gastric adenocarcinoma patients].. PubMed. 24(5). 440–448. 1 indexed citations

Li, Hongli, Jingyu Deng, Shaohua Ge, et al.. (2021). Phase II study of perioperative toripalimab in combination with FLOT in patients with locally advanced resectable gastric/gastroesophageal junction (GEJ) adenocarcinoma.. Journal of Clinical Oncology. 39(15_suppl). 4050–4050. 17 indexed citations

10.

Luo, Yang, et al.. (2021). [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases].. PubMed. 50(4). 369–375. 1 indexed citations

11.

Song, Xianzhou, Ji‐Hyun Shin, Fenglin Zang, et al.. (2020). Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer. Journal of Biological Chemistry. 295(8). 2348–2358. 15 indexed citations

12.

Meng, Zhaoting, Peng Chen, Fenglin Zang, et al.. (2017). A patient with classic biphasic pulmonary blastoma harboring<em> CD74–ROS1</em> fusion responds to crizotinib. OncoTargets and Therapy. Volume 11. 157–161. 10 indexed citations

13.

Shi, Lei, et al.. (2017). Effect of Yang -activating and stasis-eliminating decoction from Traditional Chinese Medicine on intestinal mucosal permeability in rats with ulcerative colitis induced by dextran sulfate sodium. Journal of Traditional Chinese Medicine. 37(4). 452–460. 5 indexed citations

14.

Du, Ping, Hailing Wang, Yiran Mao, et al.. (2016). Ultrasound-guided core needle biopsy in the diagnosis of neuroblastic tumors in children: a retrospective study on 83 cases. Pediatric Surgery International. 33(3). 347–353. 17 indexed citations

15.

Azizian, Nancy G., Ming Guo, Michela Capello, et al.. (2016). Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer. PLoS ONE. 11(3). e0152300–e0152300. 21 indexed citations

16.

Zhang, Ximei, Baozhong Zhang, Fenglin Zang, et al.. (2016). Clinical features and treatment of squamous cell carcinoma of the breast. OncoTargets and Therapy. 9. 3181–3181. 22 indexed citations

17.

Zang, Fenglin, Xiyin Wei, & Baocun Sun. (2014). [Relationship of c-FLIP(L) protein expression with molecular subtyping and clinical prognosis in invasive breast cancer].. PubMed. 43(7). 442–6. 3 indexed citations

18.

Zang, Fenglin, Xiyin Wei, Xue Leng, Man Yu, & Baocun Sun. (2014). C-FLIP(L) contributes to TRAIL resistance in HER2-positive breast cancer. Biochemical and Biophysical Research Communications. 450(1). 267–273. 30 indexed citations

19.

Yu, Man, Yurong Shi, Xiyin Wei, et al.. (2009). Mitochondrial DNA depletion promotes impaired oxidative status and adaptive resistance to apoptosis in T47D breast cancer cells. European Journal of Cancer Prevention. 18(6). 445–457. 26 indexed citations

20.

Zang, Fenglin, Baocun Sun, Xiulan Zhao, et al.. (2007). Critical role for c‐FLIP_L on Fas resistance in colon carcinoma cell line HT‐29. Cell Biology International. 32(3). 329–336. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact